Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

Livio Pagano, Jon Salmanton-García, Francesco Marchesi, Ola Blennow, Maria Gomes da Silva, Andreas Glenthøj, Jaap van Doesum, Yavuz M. Bilgin, Alberto López-García, Federico Itri, Raquel Nunes Rodrigues, Barbora Weinbergerová, Francesca Farina, Giulia Dragonetti, Caroline Berg Venemyr, Jens van Praet, Ozren Jaksic, Toni Valković, Iker Falces-Romero, Sonia Martín-Pérez, Moraima Jiménez, Julio Dávila-Valls, Martin Schönlein, Emanuele Ammatuna, Stef Meers, Mario Delia, Zlate Stojanoski, Anna Nordlander, Tobias Lahmer, László Imre Pinczés, Caterina Buquicchio, Klára Piukovics, Irati Ormazabal-Vélez, Nicola Fracchiolla, Michail Samarkos, Gustavo-Adolfo Méndez, José-Ángel Hernández-Rivas, Ildefonso Espigado, Martin Cernan, Verena Petzer, Sylvain Lamure, Roberta di Blasi, Joyce Marques de Almedia, Michelina Dargenio, Monika M. Biernat, Mariarita Sciumè, Cristina de Ramón, Nick de Jonge, Josip Batinić, Avinash Aujayeb, Monia Marchetti, Guillemette Fouquet, Noemí Fernández, Giovanni Zambrotta, Maria Vittoria Sacchi, Anna Guidetti, Fatih Demirkan, Lucia Prezioso, Zdeněk Ráčil, Marcio Nucci, Miloš Mladenović, Raphaël Liévin, Michaela Hanáková, Stefanie Gräfe, Uluhan Sili, Marina Machado, Chiara Cattaneo, Tatjana Adžić-Vukičević, Luisa Verga, Jorge Labrador, Laman Rahimli, Matteo Bonanni, Francesco Passamonti, Antonio Pagliuca, Paolo Corradini, Martin Hoenigl, Philipp Koehler, Alessandro Busca, Oliver A. Cornely

Blood (2022) 140 (26): 2773–2787.

https://doi.org/10.1182/blood.2022017257

Published: 2022

Includes: Supplemental data

Journal Articles

Ibrutinib Alone or in Combination with R-CHOP Chemoimmunotherapy in Relapsed or Refractory Primary Central Nervous System Lymphoma (rrPCNSL): A «Real-Life» Study

Blood (2022) 140 (Supplement 1): 6678–6680.

https://doi.org/10.1182/blood-2022-170143

Published: 2022

Journal Articles

Do MYC Alterations Matter in HIV-Associated Large B Cell Lymphomas? the "Euromyc" Study (a European retrospective study)

Chiara Pagani, Chiara Rusconi, Alessia Dalla Pria, Emanuele Ravano, Philipp Schommers, Mariana Bastos-Oreiro, Luisa Verga, Guido Gini, Michele Spina, Luca Arcaini, Sara Steffanoni, Davide Dalu, Chiara Cattaneo, Fabio Facchetti, Giuseppe Rossi, Alessandra Tucci, Alessandro Re

Blood (2021) 138 (Supplement 1): 2506.

https://doi.org/10.1182/blood-2021-151149

Published: 2021

Journal Articles

Infections in Patients with Lymphoproliferative Diseases Treated with Target Therapy. Italian Multicentric Retrospective Study Seifem 2017

Gianpaolo Nadali, MD, Gessica Marchesini, MD, Davide Facchinelli, MD, Francesca Farina, MD, Maria Chiara Tisi, MD, Federica Lessi, MD, Francesco Marchesi, Chiara Cattaneo, MD, Anna Candoni, MD, Rosa Fanci, Lucia Prezioso, MD, Luisa Verga, MD, Luca Laurenti, MD, Fabio Trastulli, MD, Marco Picardi, MD, Maria Ilaria Del Principe, MD, Ronaldo Silva, PhD, Alessandro Busca

Blood (2018) 132 (Supplement 1): 4164.

https://doi.org/10.1182/blood-2018-99-111518

Published: 2018

Journal Articles

Safety and Activity of a Dose-Dense Short-Term Chemoimmunotherapy in HIV-Positive Patients with Burkitt Lymphoma (HIV-BL pts): Final Results of the Carmen Phase II Trial

Andrés J M Ferreri, MD, Michele Spina, Chiara Cattaneo, MD, Luisa Verga, MD, Bernardino Allione, Daris Ferrari, Luigi Rigacci, Luca Fumagalli, MD, Giovanni Donadoni, MD, Arben Lleshi, MD, Marianna Sassone, MD, Giuseppe Rossi, MD, Alessandro Re, MD

Blood (2017) 130 (Supplement 1): 2828.

https://doi.org/10.1182/blood.V130.Suppl_1.2828.2828

Published: 2017

Journal Articles

Seifem 2016 Study: Incidence of Probable and Proven Invasive Aspergillosis in Patients with Acute Myeloid Leukemia during Consolidation Therapy

Maria Ilaria Del Principe, Roberta di Blasi, MD, Luisa Verga, MD, Anna Candoni, MD, Stelvio Ballanti, MD, Leonardo Potenza, Chiara Cattaneo, MD, Mario Delia, MD, Nunzia Decembrino, MD, Lorella MA Melillo, MD, Carlo Castagnola, MD, Gianpaolo Nadali, MD, Rosa Fanci, MD, Antonella Ferrari, MD, Nicola Fracchiolla, MD, Enrico Orciuolo, PhD MD, Federica Lessi, MD, Anna Chierichini, MD, Massimo Offidani, MD, Marco Picardi, MD, Lucia Prezioso, MD, Benedetta Rambaldi, MD, Francesco Marchesi, MD, Ombretta Annibali, Daniele Zama, MD, Valentina Mancini, MD, Prassede Salutari, MD, Maria Grazia Garzia, MD, Adriana Vacca, MD, Simone Cesaro, MD, Rosangela Invernizzi, MD, Katia Perruccio, MD, Maria Enza Mitra, MD, Angela Maria Quinto, MD, Maria Chiara Tisi, Bruno Martino, Adriano Venditti, MD, Alessandro Busca, Franco Aversa, MD, Livio Pagano, MD

Blood (2017) 130 (Supplement 1): 5018.

https://doi.org/10.1182/blood.V130.Suppl_1.5018.5018

Published: 2017

Journal Articles

Central Nervous System Relapse in HIV Positive Patients Affected By Diffuse Large B Cell Lymphoma. IsÂ the CNS-IPI Score Useful in This Population?

Luisa Verga, MD, Davide Dalu, Rossella Renso, Andrea Aroldi, Ilaria De Benedetto, Filippo Brioschi, Claudia Zeroli, Paola Vitiello, Fulvio Crippa, Elisa Suardi, Raffaella Epifani, Omar Giglio, Maurizio Mena, Chiara Bombonati, Elisa Colella, Andrea Gori, Carlo Gambacorti-Passerini, MD, Alessandra Bandera

Blood (2017) 130 (Supplement 1): 1567.

https://doi.org/10.1182/blood.V130.Suppl_1.1567.1567

Published: 2017

Journal Articles

Antibiotic Prophylaxis Revisited: The Impact of Fluoroquinolones on Epidemiology and on the Emergence of Resistant Strains in Acute Leukemia Patients. Results of a Prospective Study By the Rete Ematologia Lombarda (REL)

Chiara Cattaneo, MD, Patrizia Zappasodi, MD, Silvia Ferrari, MD, Francesca Pavesi, MD, Claudio Annaloro, MD, Cristina Skert, MD, Luisa Verga, MD, Elisabetta Todisco, MD, Andrea Ferrario, MD, Vittoria Saccà, Angela Passi, MD, Erika Borlenghi, MD, Matteo C Da Vià, MD, Valentina Mancini, Gabriella Mometto, Claudia Basilico, MD, Roberto Cairoli, Annamaria Nosari, Giuseppe Rossi, MD

Blood (2014) 124 (21): 4125.

https://doi.org/10.1182/blood.V124.21.4125.4125

Published: 2014

Journal Articles

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma at High Risk (aa-IPI 2-3). Mature Results of a Multicenter Prospective Phase II Trial

Alessandro Re, MD, Chiara Cattaneo, MD, Salvatore Casari, MD, Guido Gini, MD, Mariagrazia Michieli, Bernardino Allione, Luisa Verga, MD, Caterina Bocci, Michele Spina, MD, Stefania Tamiazzo, Alessandra Bandera, Flavia Salvi, MD, Annalisa Peli, MD, Moira Micheletti, Camillo Almici, MD, Pierino Ferremi, Umberto Tirelli, MD, Giuseppe Rossi, MD

Blood (2014) 124 (21): 2528.

https://doi.org/10.1182/blood.V124.21.2528.2528

Published: 2014

Journal Articles

Invasive Fungal Infections in Acute Promyelocytic Leukemia Patients. Results of a Prospective Multicenter Study in Italy

Blood (2014) 124 (21): 3682.

https://doi.org/10.1182/blood.V124.21.3682.3682

Published: 2014

Journal Articles

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma At High Risk (Aaipi 2–3). an Interim Report of a Multicenter Phase II Trial.

Alessandro Re, MD, Mariagrazia Michieli, Bernardino Allione, MD, Salvatore Casari, MD, Chiara Cattaneo, MD, Michele Spina, Andrea Gori, Elisa Garlassi, Luisa Verga, MD, Camillo Almici, MD, Pierino Ferremi, Mario Mazzucato, Alessandro Levis, MD, Umberto Tirelli, MD, Giuseppe Rossi, MD

Blood (2012) 120 (21): 3124.

https://doi.org/10.1182/blood.V120.21.3124.3124

Published: 2012

Journal Articles

Clinical Activity of Crizotinib In Advanced, Chemoresistant ALK+ Lymphoma Patients

Carlo B Gambacorti-Passerini, Ilaria Dilda, Giovanni Giudici, Alessandra Perego, Francesca Pavesi, Luca Guerra, Lorenza Borin, Ivana Casaroli, Marilena Fedele, Luisa Verga, Enrico Maria Pogliani

Blood (2010) 116 (21): 2877.

https://doi.org/10.1182/blood.V116.21.2877.2877

Published: 2010

Journal Articles

Extranodal Non-Hodgkin’s Lymphoma. A Study of 182 Patients with Analysis of Prognostic Factors.

Enrico Maria Pogliani, M.D., Fausto Rossini, M.D., Veronica Coccini, M.D., Alessandra Larocca, M.D., Luisa Verga, M.D., Sara Marinoni, M.D., Anna Brizio, M.D., Elena Elli, M.D.

Blood (2004) 104 (11): 4557.

https://doi.org/10.1182/blood.V104.11.4557.4557

Published: 2004

NARROW

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

Ibrutinib Alone or in Combination with R-CHOP Chemoimmunotherapy in Relapsed or Refractory Primary Central Nervous System Lymphoma (rrPCNSL): A «Real-Life» Study

Do MYC Alterations Matter in HIV-Associated Large B Cell Lymphomas? the "Euromyc" Study (a European retrospective study)

Infections in Patients with Lymphoproliferative Diseases Treated with Target Therapy. Italian Multicentric Retrospective Study Seifem 2017

Safety and Activity of a Dose-Dense Short-Term Chemoimmunotherapy in HIV-Positive Patients with Burkitt Lymphoma (HIV-BL pts): Final Results of the Carmen Phase II Trial

Seifem 2016 Study: Incidence of Probable and Proven Invasive Aspergillosis in Patients with Acute Myeloid Leukemia during Consolidation Therapy

Central Nervous System Relapse in HIV Positive Patients Affected By Diffuse Large B Cell Lymphoma. IsÂ the CNS-IPI Score Useful in This Population?

Antibiotic Prophylaxis Revisited: The Impact of Fluoroquinolones on Epidemiology and on the Emergence of Resistant Strains in Acute Leukemia Patients. Results of a Prospective Study By the Rete Ematologia Lombarda (REL)

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma at High Risk (aa-IPI 2-3). Mature Results of a Multicenter Prospective Phase II Trial

Invasive Fungal Infections in Acute Promyelocytic Leukemia Patients. Results of a Prospective Multicenter Study in Italy

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma At High Risk (Aaipi 2–3). an Interim Report of a Multicenter Phase II Trial.

Clinical Activity of Crizotinib In Advanced, Chemoresistant ALK+ Lymphoma Patients

Extranodal Non-Hodgkin’s Lymphoma. A Study of 182 Patients with Analysis of Prognostic Factors.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only